It was not immediately clear why the talks stalled, but this comes as U.S. companies considering tax inversions come under intense pressure.» Read More
Some of the names on the move ahead of the open.
Noted hedge-fund manager David Tepper is right to be nervous about this market, investment manager Michael Farr told CNBC Thursday.
The Chinese government has imposed new limits on foreign brands of milk powder and infant formula.
France's Sanofi and U.S. drugmakers Merck& Co and Abbott Laboratories are exploring selling off their mature drugs that have lost patent protection, Reuters reported this week, citing people familiar with the plans.
In a brief filed with the 9th U.S. Circuit Court of Appeals in San Francisco on Thursday, AbbVie Inc said the full court should review an initial three-judge decision that found a gay man was improperly excluded from jury service due to his sexual orientation.
U.S. bonds fell back on Wednesday, as the previous session's stock market rally caused investors' bid for "safe-haven" assets to wane.
U.S. stock index futures traded higher on Wednesday, ahead of a busy day for bank, tech and pharmaceutical earnings.
It's a long play, but emerging markets promise significant growth for the health-care industry, said Abbott CFO Thomas Freyman.
"The world is going to want to find a compromise," said David Kelly, chief market strategist at J.P. Morgan Funds.
Wednesday's midday movers:
What 10 stocks does trader Michael Farr think are going to deliver in 2014? Click ahead to find out.
It’s time for the Lightning Round. Cramer makes the call on viewer favorites.
Westwood Holding Group’s Mark Freeman has investment recommendations for companies less dependent on Fed stimulus.
Has Washington distracted you from these money making developments?
Take a look at some of Wednesday's midday movers:
U.S. stock index futures pointed to a higher open on Wednesday, with lawmakers looking to strike a deal to lift the country's borrowing limit before Thursday's deadline.
With a deadline hanging over Congress, stocks could be whipped by headlines from Washington but should ultimately be able to limp through the drama.
On the heels of Microsoft boosting its dividend and renewing its buyback, there are a host of other companies that could be candidates for the same.
We could be witnessing the beginning of a merger wave in biotech, Jim Cramer said Tuesday.
China fined six companies including New Zealand dairy giant Fonterra a total of $110 million following an investigation into price fixing and anti-competitive practices by foreign baby formula makers.